Journal
/
/
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
DOI:

09:50 min

April 10, 2020

, ,

Chapters

  • 00:04Introduction
  • 00:54Fluorescently Labeling Cells with DiI(1,1 -Dioctadecyl-3,3,3 ,3 -Tetramethylindocarbocyanine Perchlorate)
  • 02:10Microinjecting Zebrafish Larvae
  • 04:37Setting up Drug Screen with Xenografted Zebrafish
  • 06:22Imaging Xenografted Zebrafish and Quantifying Fluorescence
  • 08:36Results: Xenografted Tumor Area
  • 09:22Conclusion

Summary

Automatic Translation

Zebrafish xenograft models allow for high-throughput drug screening and fluorescent imaging of human cancer cells in an in vivo microenvironment. We developed a workflow for large scale, automated drug screening on patient-derived leukemia samples in zebrafish using an automated fluorescence microscope equipped imaging unit.

Related Videos

Read Article